ExodusPoint Capital Management’s Kindred Biosciences, Inc. KIN Stock Holding History

ExodusPoint Capital Management’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-30,100	Closed	-$276K	–	2908
2021 Q2	$276K	Buy	+30,100	New	+$175K	﹤0.01%	1792

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

ExodusPoint Capital Management's KIN Position: Q3 2021 in Review

ExodusPoint Capital Management sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 22,669 shares — an estimated $208K sold.

ExodusPoint Capital Management first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $208K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

ExodusPoint Capital Management reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
ExodusPoint Capital Management sold 22,669 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $208K.
ExodusPoint Capital Management first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
ExodusPoint Capital Management's Kindred Biosciences, Inc. position peaked at $208K in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.